Previous studies demonstrated that administration of ACE2 activator increased ACE2 expression and activity while decreased AT1R expression in the myocardium of rats with DCM (Murça et al., 2012a; Murça et al., 2012b). This evidence concerns the gene AGTR1 and familial dilated cardiomyopathy.